🔥Telegram İfşa

For the first time, anyone who needs a bone-marrow transplant should be able to easily find a donor. @SarahZhang reports: theatlantic.com/health/archive…

Woman gets xeno-kidney with only one gene knockout (alpha-gal) and is doing well so far. Is one gene edit enough? The patent covering alpha-gal knockout is expired, which may partly explain why others are intent on multiple genetic alterations. technologyreview.com/2024/04/24/109…

A reminder that anyone with relevant interests or expertise can comment on an Arcadia Science publication. We think folks at any career stage can pose useful comments or questions. Posting public comments on our work is a great way to engage directly with our scientists, get help

.ASAPbio and Arcadia Science invite you for a discussion on gauging the impact of science! Join Prachee Avasthi, Robert Roth, and Jonny Coates (jacoates.bsky.social) for an interactive virtual discussion on Wednesday, May 29th, at 9 a.m. PT. Register here 👇 buff.ly/3UWibtc

Our first publication Arcadia Science went live May 31, 2022, exactly 2 years ago, and we just hit 50 pubs today! HUGE congrats to all Arcadians! ❤️🙌🎉

We know many of you have been following our publishing experiment Arcadia Science. We learned a lot from publishing this way and also it was clear something needed to change. Take a look at the next iteration of our model, putting the scientists back in the driver’s seat while

v2.0 of our publishing approach comes with a new X account! Follow to hear about Arcadia’s research and our open science experiment. research.arcadiascience.com

Introducing peptigate (peptide+investigate), a workflow that predicts and annotates peptides from transcriptome assemblies. It predicts small ORF-encoded peptides, cleavage peptides, and ribosomally synthesized and posttranslationally modified peptides.🧵 github.com/Arcadia-Scienc…

📢 Arcadia Science is hiring a Protein Biochemist! Are you excited about proteins and eager to learn more? Are you looking to contribute to collaborative projects by leading efforts to purify and characterize proteins? If so, apply now! 👉 jobs.lever.co/arcadiascience…

Today in Science Magazine we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells, a collaboration with Sternberg Lab. 1/13 drive.google.com/file/d/1I-UbCR…

This is legitimately amazing

New nature The possibility that lithium deficiency is a driver of Alzheimer's disease. Experimental model shows Li depletion impedes amyloid clearance, and repletion in humans could be achieved with low doses nature.com/articles/s4158…